MedTrace Logo

ProMRI 3T ENHANCED Master Study

NCT02506569 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2018-02-07

No results posted yet for this study

Summary

The investigation is designed to provide supporting evidence for the clinical safety of the Biotronik's new Implantable Cardioverter Defibrillator systems when used under specific 3 Tesla MR conditions .

Conditions

  • Safety of MR (Magnetic Resonance)-Conditional ICDs

Interventions

DEVICE

Implantable Cardioverter Defibrillator therapy

Tachycardia Fast Heart Beat

OTHER

Magnetic Resonance Imaging (MRI)

MRI scan of the head and lower body parts

Sponsors & Collaborators

  • Biotronik SE & Co. KG

    lead INDUSTRY

Principal Investigators

  • Rainer Zbinden, Dr. · Triemli Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2018-01-15
Completion
2018-01-15

Countries

  • Australia
  • Austria
  • Germany
  • Singapore
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02506569 on ClinicalTrials.gov